Inventor · disambiguated record
Yaohe Wang
Also filed as: WANG YAOHE
9 granted patents·4 pending applications·17 citations·filing 2008–2023
81Inventor score
Files withBEIJING BIO TARGETING THERAPEUTICS TECH INC4UNIV LONDON QUEEN MARY4BEIJING BIO TARGETING THERAPEUTICS TECHNOLOGY INC2BALKWILL FRANCES1CANCER RESEARCH TECH LTD1
Top patents by PatentIndex Score
13 records- 0188US10294493B2Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the sameBEIJING BIO TARGETING THERAPEUTICS TECH INC·Filed 2018·Granted May 21, 2019·8 cites·2 claims
- 0282US9315827B2Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the sameBEIJING BIO TARGETING THERAPEUTICS TECHNOLOGY INC·Filed 2013·Granted Apr 19, 2016·8 cites·3 claims
- 0367US11345732B2Modified interleukin 12 and use thereof in preparing drugs for treating tumoursBEIJING BIO TARGETING THERAPEUTICS TECH INC·Filed 2016·Granted May 31, 2022·1 cites·5 claims
- 0463US2023293608A1Oncolytic Vaccinia VirusUNIV LONDON QUEEN MARY·Filed 2023·Application pending·0 cites
- 0555US2022213161A1Modified interleukin 12 and use thereof in preparing drugs for treating tumoursBEIJING BIO TARGETING THERAPEUTICS TECH INC·Filed 2022·Application pending·0 cites
- 0654US12509704B2Oncolytic vaccinia virus with modified B5R gene for the treatment of cancerUNIV LONDON QUEEN MARY·Filed 2019·Granted Dec 30, 2025·0 cites·13 claims
- 0753US9932606B2Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the sameBEIJING BIO TARGETING THERAPEUTICS TECH INC·Filed 2016·Granted Apr 3, 2018·0 cites·5 claims
- 0851US12194145B2SiRNA delivery system compound as well as preparation method and application thereofUNIV ZHENGZHOU·Filed 2021·Granted Jan 14, 2025·0 cites·4 claims
- 0947US9134293B2Cancer marker and therapeutic targetBALKWILL FRANCES·Filed 2008·Granted Sep 15, 2015·0 cites·18 claims
- 1041US10261099B2Cancer marker and therapeutic targetCANCER RESEARCH TECH LTD·Filed 2015·Granted Apr 16, 2019·0 cites·6 claims
- 1139US11351209B2Inhibitors of PI3K p-delta 110 for use in delivery of viruses in the treatment of cancerUNIV LONDON QUEEN MARY·Filed 2017·Granted Jun 7, 2022·0 cites·6 claims
- 1233US2017020938A1Oncolytic Vaccinia VirusUNIV LONDON QUEEN MARY·Filed 2015·Application pending·0 cites
- 1333US2013345295A1Targeted oncolytic adenovirus for treatment of human tumors, constrcution method and application thereofBEIJING BIO TARGETING THERAPEUTICS TECHNOLOGY INC·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →